These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 29863943)

  • 21. Piperacillin/tazobactam-induced paresthesiae.
    Lambourne J; Kitchen J; Hughes C; Merry C
    Ann Pharmacother; 2006 May; 40(5):977-9. PubMed ID: 16622157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suspected drug reaction with piperacillin/tazobactam, in a premature infant.
    Maulidi H; Godambe S; Chow P
    Br J Clin Pharmacol; 2008 Jun; 65(6):971-2. PubMed ID: 18307542
    [No Abstract]   [Full Text] [Related]  

  • 23. Ertapenem versus piperacillin/tazobactam for diabetic foot infections in China: a Phase 3, multicentre, randomized, double-blind, active-controlled, non-inferiority trial.
    Xu ZR; Ran XW; Xian Y; Yan XD; Yuan GY; Mu SM; Shen JF; Zhang BS; Gan WJ; Wang J
    J Antimicrob Chemother; 2016 Jun; 71(6):1688-96. PubMed ID: 26888908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Piperacillin/tazobactam induced thrombocytopaenia--a delayed response.
    Macwilliam JL; Mistry R; Floyd MS; Baird AD
    BMJ Case Rep; 2012 Jul; 2012():. PubMed ID: 22778457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.
    Anderson CW; Cazares KS; Lustik MB; Patel SM; Denunzio TM
    Mil Med; 2017 Sep; 182(9):e1773-e1778. PubMed ID: 28885936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the incidence of vancomycin-induced nephrotoxicity in hospitalized patients with and without concomitant piperacillin-tazobactam.
    Burgess LD; Drew RH
    Pharmacotherapy; 2014 Jul; 34(7):670-6. PubMed ID: 24855041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrolytes imbalance: a rare side effect of piperacillin/ tazobactam therapy.
    Hussain S; Syed S; Baloch K
    J Coll Physicians Surg Pak; 2010 Jun; 20(6):419-20. PubMed ID: 20642978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute generalized exanthematous pustulosis: a rare clinical entity with use of piperacillin/tazobactam.
    Talati S; Lala M; Kapupara H; Thet Z
    Am J Ther; 2009; 16(6):591-2. PubMed ID: 19352142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemolytic anemia as a result of piperacillin/tazobactam administration: a case report and discussion of pathophysiology.
    Zanetti RC; Biswas AK
    Mil Med; 2013 Sep; 178(9):e1045-7. PubMed ID: 24005557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Piperacillin and vancomycin induced severe thrombocytopenia in a hospitalized patient.
    Anand A; Chauhan HK
    Platelets; 2011; 22(4):294-301. PubMed ID: 21309645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial.
    Kaye KS; Bhowmick T; Metallidis S; Bleasdale SC; Sagan OS; Stus V; Vazquez J; Zaitsev V; Bidair M; Chorvat E; Dragoescu PO; Fedosiuk E; Horcajada JP; Murta C; Sarychev Y; Stoev V; Morgan E; Fusaro K; Griffith D; Lomovskaya O; Alexander EL; Loutit J; Dudley MN; Giamarellos-Bourboulis EJ
    JAMA; 2018 Feb; 319(8):788-799. PubMed ID: 29486041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fever and Reversible Laboratory Abnormalities Associated with Prolonged Use of Piperacillin-Tazobactam in Children.
    Patel A; Mao KR; McNeil JC; Kaplan SL; Vallejo JG
    Pediatr Infect Dis J; 2015 Aug; 34(8):849-50. PubMed ID: 25961892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic evaluation of piperacillin-tazobactam.
    Hayashi Y; Roberts JA; Paterson DL; Lipman J
    Expert Opin Drug Metab Toxicol; 2010 Aug; 6(8):1017-31. PubMed ID: 20636224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piperacillin-Tazobactam Induced Interstitial Nephritis, Hepatitis and Serum Sckness-Like Illness.
    Kraleti S; Khatri N; Jarrett D
    J Ark Med Soc; 2016 Jun; 112(14):278-80. PubMed ID: 27434982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefepime challenge after piperacillin/tazobactam-induced thrombocytopenia.
    Beaulieu C; Kurczewski L; Yajnik V
    J Thromb Thrombolysis; 2019 Jul; 48(1):167-170. PubMed ID: 30968302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of galactomannan in surgical patients receiving perioperative piperacillin/tazobactam prophylaxis.
    Machetti M; Majabo MJ; Furfaro E; Solari N; Novelli A; Cafiero F; Viscoli C
    J Antimicrob Chemother; 2006 Oct; 58(4):806-10. PubMed ID: 16943210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of tazobactam pharmacokinetics on the antimicrobial effect of piperacillin-tazobactam combinations.
    Liu Q; Rand K; Derendorf H
    Int J Antimicrob Agents; 2004 May; 23(5):494-7. PubMed ID: 15120729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced immune-mediated thrombocytopenia in the intensive care unit.
    Bose S; Wurm E; Popovich MJ; Silver BJ
    J Clin Anesth; 2015 Nov; 27(7):602-5. PubMed ID: 26260647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generalized fixed drug eruption to piperacillin/tazobactam and review of literature.
    Kornmehl H; Gorouhi F; Konia T; Fung MA; Tartar DM
    Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is the Combination of Piperacillin-Tazobactam and Vancomycin Associated with Development of Acute Kidney Injury? A Meta-analysis.
    Giuliano CA; Patel CR; Kale-Pradhan PB
    Pharmacotherapy; 2016 Dec; 36(12):1217-1228. PubMed ID: 27805728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.